161 related articles for article (PubMed ID: 38045157)
1. Alterations in the intestinal microbiota associated with active tuberculosis and latent tuberculosis infection.
Huang Y; Tang J; Cai Z; Qi Y; Jiang S; Ma T; Yue Y; Huang F; Yang H; Ma Y
Heliyon; 2023 Nov; 9(11):e22124. PubMed ID: 38045157
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis.
Huang Y; Tang JH; Cai Z; Qi Y; Jiang S; Ma TT; Yue Y; Huang F; Yang H; Ma YY
Tuberculosis (Edinb); 2022 Sep; 136():102231. PubMed ID: 35964506
[TBL] [Abstract][Full Text] [Related]
3. The potential mechanism of the progression from latent to active tuberculosis based on the intestinal microbiota alterations.
Luo D; Shi CY; Wei NS; Yang BY; Qin K; Liu G; Dong BQ; Qin YX; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Li H; Li J
Tuberculosis (Edinb); 2023 Dec; 143():102413. PubMed ID: 37832478
[TBL] [Abstract][Full Text] [Related]
4. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
5. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of
Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X
Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824
[TBL] [Abstract][Full Text] [Related]
8. RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Active and Latent
Lv L; Li C; Zhang X; Ding N; Cao T; Jia X; Wang J; Pan L; Jia H; Li Z; Zhang J; Chen F; Zhang Z
Front Microbiol; 2017; 8():1051. PubMed ID: 28659881
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
[TBL] [Abstract][Full Text] [Related]
10.
Meng R; Dong W; Gao J; Lu C; Zhang C; Liao Q; Chen L; Wu H; Hu J; Wei W; Jiang Z
Indian J Microbiol; 2022 Sep; 62(3):374-383. PubMed ID: 35974910
[TBL] [Abstract][Full Text] [Related]
11. Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification.
Luo D; Yang BY; Qin K; Shi CY; Wei NS; Li H; Qin YX; Liu G; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Dong BQ; Li J
Infect Drug Resist; 2023; 16():6121-6138. PubMed ID: 37719654
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Potential of the Serological Response to Synthetic Peptides from
Araujo Z; de Waard JH; Camargo M; Lopez-Ramos JE; de Larrea CF; Vanegas M; Patarroyo MA
Int J Pept Res Ther; 2022; 28(3):98. PubMed ID: 35528735
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte-Related Immunological Indicators for Stratifying
Luo Y; Xue Y; Tang G; Cai Y; Yuan X; Lin Q; Song H; Liu W; Mao L; Zhou Y; Chen Z; Zhu Y; Liu W; Wu S; Wang F; Sun Z
Front Immunol; 2021; 12():658843. PubMed ID: 34276653
[TBL] [Abstract][Full Text] [Related]
14. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
[TBL] [Abstract][Full Text] [Related]
15. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
[TBL] [Abstract][Full Text] [Related]
17. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota composition can reflect immune responses of latent tuberculosis infection in patients with poorly controlled diabetes.
Huang HL; Luo YC; Lu PL; Huang CH; Lin KD; Lee MR; Cheng MH; Yeh YT; Kao CY; Wang JY; Yang JM; Chong IW
Respir Res; 2023 Jan; 24(1):11. PubMed ID: 36631857
[TBL] [Abstract][Full Text] [Related]
19. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
[TBL] [Abstract][Full Text] [Related]
20. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
